| Abstract | The effects of percutaneous Ethibloc (Ethicon/Johnson & Johnson, St-Stevens-Woluwe, Belgium) injection into primary aneurysmal bone cysts were analysed. Two patients with a venous drainage after injection of a medium contrast were excluded. Twelve patients underwent at least one percutaneous injection of Ethibloc. The average follow-up period was 5.1 years. At final follow-up, six patients had complete healing of the cyst, three had partial healing and three, who had no response, were treated by curettage and bone grafting. Complete healing was observed for all the aggressive lesions. No major complications were noted. Ethibloc injection may be performed as a primary treatment of aneurysmal bone cysts if the technique is followed with precision. |
| Authors | Jérôme Sales de Gauzy, Abdelazis Abid, Franck Accadbled, Gorka Knorr, Philippe Darodes, Jean Philippe Cahuzac
(Affiliation: Department of Orthopaedic Pediatric Surgery, CHU, Toulouse, France.)
|
| Journal | Journal of pediatric orthopaedics. Part B / European Paediatric Orthopaedic Society, Pediatric Orthopaedic Society of North America
(J Pediatr Orthop B)
Vol. 14
Issue 5
Pg. 367-70
(Sep 2005)
ISSN: 1060-152X United States |
| PMID | 16093949
(Publication Type: Clinical Trial, Journal Article)
|
| Chemical References |
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents, Non-Steroidal
- Drug Combinations
- Fatty Acids
- Propylene Glycols
- Sclerosing Solutions
- Acetaminophen
- Diatrizoate
- Zein
- alcoholic prolamine solution
|
| Topics |
- Acetaminophen
(therapeutic use)
- Adolescent
- Analgesics, Non-Narcotic
(therapeutic use)
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Bone Cysts, Aneurysmal
(drug therapy)
- Child
- Child, Preschool
- Diatrizoate
(therapeutic use)
- Drug Combinations
- Fatty Acids
(therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Injections, Intralesional
- Male
- Propylene Glycols
(therapeutic use)
- Sclerosing Solutions
(therapeutic use)
- Treatment Outcome
- Zein
(therapeutic use)
|
